U.S. LT； P GT； Invention and Amp； Oacute； N refers to M AMP； EACUTE； all for the local management of chemotherapeutics and amperes； EACUTE； utico a UN a uroterial carcino del tracto superior (UTUC). M AMP； EACUTE； all including the installation of a CAT AMP； EACUTE； TER and BAL AMP； OACUTE； N has a working channel and a BAL AMP； OACUTE； N in UR AMP； EACUTE； TER/PELLVIS Renal A TRAV AMP； EACUTE； S de access URETRAL REPORT AMP； OACUTE； GRA AN AMP； OACUTE； GRAMP； CUT EAT (3) temporary blocking UR AMP； EACUTE； TER； Instilar formula； OACUTE； N liposomal, including chemical agents AMP； EACUTE； usefulness in the working channels of CAT AMP； EACUTE； TER；Formulas and ampoules are allowed； Oacute； N liposomal is allowed to be implanted in UR AMP； EACUTE； TER and/or kidney pelvis long enough for at least part of the formulation and ampoules； Oacute； N liposomal is attached to the European soil wall. In M AMP, EACUTE, all inventions and AMP, OACUTE, N (at least one Poci AMP), OACUTE, N (formula and AMP), OACUTE, N (chemotherapeutic agent and ampere), EACUTE, embedded tools are pasted on the European Union wall during hypnosis and delays of UR AMP, EACUTE, TER and/or PELLVIS Renal. M AMP； EACUTE； all descriptions can be used as ADYUVANTE for other M AMP； EACUTE； all Utuc therapies,For example: ABLACI AMP； OACUTE； N URETROSC AMP； OACUTE； PICA or RECECI AMP； OACUTE； N del tumors. LT； /P GT；<；p>；LA INVENCIÓ；N SE REFIERE A MÉ；TODOS PARA ADMINISTRAR LOCALMENTE UN AGENTE QUIMIOTERAPÉ；UTICO A UN CARCINOMA UROTELIAL DEL TRACTO SUPERIOR (UTUC). LOS MÉ；TODOS CONSISTEN EN COLOCAR UN CATÉ；TER CON BALÓ；N QUE TIENE UN CANAL DE TRABAJO Y UN BALÓ；N EN EL URÉ；TER / PELVIS RENAL A TRAVÉ；S DEL ACCESO URETERAL RETRÓ；GRADO O ANTERÓ；GRADO； INFLAR EL GLOBO DEL CATÉ；TER PARA OBSTRUIR TEMPORALMENTE EL URÉ；TER； INFUNDIR (INSTILAR) UNA FORMULACIÓ；N LIPOSOMAL QUE INCLUYE UN AGENTE QUIMIOTERAPÉ；UTICO EN EL C
